First transgenic primate model created for hepatitis B research
Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...
News Medical14h
The growing list of human viruses: Are we prepared for the next outbreak?
Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...
Some viruses 'freeze' their RNA to replicate, study finds
They say that change takes time. Well, that's not the case for RNA. The small biological molecule acts like a switchboard ...
Q&A: Professor discusses using light to 'hear' viruses
Elad Harel is used to shining a light on the mysteries of the natural world. Working at the cutting-edge of ultrafast ...
Physics World2d
Nanoparticles demonstrate new and unexpected mechanism of coronavirus disinfection
Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...
AZoLifeSciences on MSN2d
Gene Delivery Systems: Viral vs. Non-Viral Vectors
This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...
Theralase achieves breakthrough Herpes treatment
Clinical-stage pharma stock Theralase Technologies (TSXV:TLT) announced a significant breakthrough in the treatment of Herpes ...
Le Lézard3d
Theralase(R) Releases Latest Research on Inactivation of Herpes Simplex Viruses
University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of Herpes Simplex Viruses post infection. TORONTO, ON / ACCESS Newswire / ...
Theralase Technologies, Inc.: Theralase Releases Latest Research on Inactivation of Herpes Simplex Viruses
University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of Herpes Simplex Viruses post infection. TORONTO, ON / ACCESS Newswire / Febru ...